标普和纳斯达克内在价值 联系我们

Viridian Therapeutics, Inc. VRDN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.10
+189.7%

Viridian Therapeutics, Inc. (VRDN) has 20 已知的内部人和机构持有人记录. 最大持有人为 Logos Global Master Fund LP 持有 6,000,000 股. 其他重要持有人包括 Fairmount Funds Management LLC 和 Atlas Venture Fund VII L P.

过去12个月,内部人进行了 25 笔交易,涉及 VRDN 股票 — 12 笔买入 (价值为 $11.82M) 和 1 笔卖出 (价值为 $70.8K). 内部人买入超过卖出,可能表明对公司前景有信心.

VRDN 內部人持股

最大持股人
Logos Global Master Fund LP
6,000,000 股
买入(12个月)
12
$11.82M 价值
卖出(12个月)
1
$70.8K 价值
12个月交易活动
买入 48%
卖出 4%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Logos Global Master Fund Lp 10 Percent Owner 6,000,000 2020-11-16
100%
2 Fairmount Funds Management Llc 10 Percent Owner 3,914,458 2025-10-27
65%
3 Atlas Venture Fund Vii L P 10 Percent Owner 3,142,580 2017-02-13
52%
4 Remeditex Ventures Llc 10 Percent Owner 2,706,563 2017-02-13
45%
5 Frazier Life Sciences Public Fund, L.p. 10 Percent Owner 1,505,200 2021-09-28
25%
6 Fairmount Healthcare Fund Ii L.p. Director 1,363,764 2022-08-19
23%
7 Marshall William Stuart President & CEO 464,000 2020-02-14
8%
8 Point72 Asset Management, L.p. 10 Percent Owner 426,162 2020-11-20
7%
9 Ra Capital Management, L.p. 10 Percent Owner 410,686 2020-12-17
7%
10 Leverone Jason A. Chief Financial Officer 311,785 2021-01-20
5%
11 Escolar Diana Chief Medical Officer 270,000 2020-02-14
5%
12 Myers Scott Dunseth Chief Executive Officer 259,500 2023-04-12
4%
13 Violin Jonathan Chief Executive Officer 239,205 2023-02-07
4%
14 Riccitelli Samuel D President & CEO 200,000 2016-05-19
3%
15 Katz Barrett Chief Medical Officer 108,000 2023-02-10
2%
16 Humer Kristian CFO and Cbo 108,000 2023-02-10
2%
17 Rubin Paul D EVP, Research & Development 87,000 2019-02-08
1%
18 Levy Adam Scott Chief Business Officer 74,000 2019-02-08
1%
19 Melvin Carrie COO 54,000 2023-02-10
1%
20 Ciulla Thomas Chief Medical Officer 50,000 2024-02-07
1%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-03-03 Tousignant Jennifer Chief Legal Officer RSU 预扣税 1,675 $30.19 $50.57K
2026-03-03 Harmon Seth Chief Financial Officer RSU 预扣税 2,031 $30.19 $61.32K
2026-03-03 Mahoney Stephen F. President and CEO RSU 预扣税 7,408 $30.19 $223.65K
2026-03-03 Beetham Thomas W. Chief Operating Officer RSU 预扣税 3,048 $30.19 $92.02K
2026-03-03 Tousignant Jennifer Chief Legal Officer RSU 预扣税 1,724 $29.32 $50.55K
2026-03-02 Tousignant Jennifer Chief Legal Officer 限制性股票授予 (RSU) 23,850 - -
2025-03-03 Tousignant Jennifer Officer 未知 - - -
2026-03-03 Harmon Seth Chief Financial Officer RSU 预扣税 2,091 $29.32 $61.31K
2026-03-02 Harmon Seth Chief Financial Officer 限制性股票授予 (RSU) 20,550 - -
2025-03-03 Harmon Seth Officer 未知 - - -
2026-03-02 Tripuraneni Radhika Chief Medical Officer 限制性股票授予 (RSU) 19,150 - -
2026-03-03 Mahoney Stephen F. President and CEO RSU 预扣税 7,627 $29.32 $223.62K
2026-03-02 Mahoney Stephen F. President and CEO 限制性股票授予 (RSU) 111,900 - -
2026-03-03 Beetham Thomas W. Chief Operating Officer RSU 预扣税 3,138 $29.32 $92.01K
2026-03-02 Beetham Thomas W. Chief Operating Officer 限制性股票授予 (RSU) 35,300 - -
2025-12-31 Tousignant Jennifer Chief Legal Officer 知情卖出 2,272 $31.16 $70.8K
2025-10-23 Fairmount Funds Management Llc 10 Percent Owner 知情买入 454,545 $22.00 $10M
2025-07-01 Gheuens Sarah Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-07-01 Kiselak Tomas Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-07-01 Cain Christopher W. Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-07-01 Moses Jennifer K. Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-07-01 Ajer Jeffrey Robert Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-07-01 Morris Arlene Director 限制性股票授予 (RSU) 21,000 $14.47 $303.87K
2025-06-10 Fairmount Funds Management Llc 10 Percent Owner 期权行权(卖出) 12,500 $12.31 $153.88K
2025-06-09 Fairmount Funds Management Llc 10 Percent Owner 期权行权(卖出) 1,600 $7.80 $12.48K
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言